New therapeutic strategy against age-related vascular injury targetedto L-type amino acid transporter
针对L型氨基酸转运蛋白的年龄相关性血管损伤新治疗策略
基本信息
- 批准号:22590665
- 负责人:
- 金额:$ 2.83万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2010
- 资助国家:日本
- 起止时间:2010 至 2012
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
A series of in vivo and in vitro experiments have revealed that L-type amino acid transporter 1 (LAT1) is pivotal for the growth of cultured vascular smooth muscle cells, and the growth of intimal thickening in the injured artery. And, therapeutic experiments targeted to LAT1 in the vascular smooth muscle cells inhibited intimal growth of the artery. These results indicate a new therapeutic LAT1-targeted strategy against age-related vascular injury.
一系列体内和体外实验表明,l型氨基酸转运蛋白1 (LAT1)对培养血管平滑肌细胞的生长和损伤动脉内膜增厚的生长起着关键作用。并且,针对血管平滑肌细胞中的LAT1的治疗实验抑制了动脉内膜的生长。这些结果表明了一种针对年龄相关血管损伤的新的靶向治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
L-type amino acid transporter 1-mediated smooth muscle proliferation and viability, and evidence of its role in neointima formation
L型氨基酸转运蛋白1介导的平滑肌增殖和活力及其在新内膜形成中作用的证据
- DOI:
- 发表时间:2012
- 期刊:
- 影响因子:0
- 作者:Kumiko Nagai;Hitomi Koshiba;Shigeki Shibata;Koichi Kozaki
- 通讯作者:Koichi Kozaki
Effects of dehydroepiandrosterone supplementation on cognitive function and activities of daily living in older women with mild to moderate cognitive impairment
- DOI:10.1111/j.1447-0594.2010.00625.x
- 发表时间:2010-10-01
- 期刊:
- 影响因子:3.3
- 作者:Yamada, Shizuru;Akishita, Masahiro;Ouchi, Yasuyoshi
- 通讯作者:Ouchi, Yasuyoshi
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KOZAKI Koichi其他文献
KOZAKI Koichi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KOZAKI Koichi', 18)}}的其他基金
Novel approach to vascular injury by targeting amino acid transporter LAT1
通过靶向氨基酸转运蛋白 LAT1 治疗血管损伤的新方法
- 批准号:
19590543 - 财政年份:2007
- 资助金额:
$ 2.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigation of the usefulness of pentoxifylline for liver preservation
己酮可可碱在肝脏保存中的有效性研究
- 批准号:
08671387 - 财政年份:1996
- 资助金额:
$ 2.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Vascular injury and repair predict divergent late onset cardiovascular morbidities after chlorine and sulfur mustard exposure
血管损伤和修复预测氯和硫芥暴露后不同的迟发性心血管疾病
- 批准号:
10712025 - 财政年份:2023
- 资助金额:
$ 2.83万 - 项目类别:
Monocyte chemoattractant Proteins and Vascular Injury
单核细胞趋化蛋白与血管损伤
- 批准号:
10732564 - 财政年份:2023
- 资助金额:
$ 2.83万 - 项目类别:
Radiation-induced Salivary Gland Vascular Injury: Mechanisms and Interventions
辐射引起的唾液腺血管损伤:机制和干预措施
- 批准号:
10701306 - 财政年份:2022
- 资助金额:
$ 2.83万 - 项目类别:
Dysregulated Adiponectin Transmembrane Signaling in Diabetic Coronary Vascular Injury and Heart Failure
糖尿病冠状血管损伤和心力衰竭中脂联素跨膜信号传导失调
- 批准号:
10363973 - 财政年份:2022
- 资助金额:
$ 2.83万 - 项目类别:
The Lung Endothelium as an Instructive Niche for the Innate Immune System during Vascular Injury
肺内皮细胞作为血管损伤期间先天免疫系统的指导性生态位
- 批准号:
10494611 - 财政年份:2022
- 资助金额:
$ 2.83万 - 项目类别:
Imbalance Between Vascular Injury and Repair in PAH
PAH 中血管损伤与修复之间的不平衡
- 批准号:
469687 - 财政年份:2022
- 资助金额:
$ 2.83万 - 项目类别:
Operating Grants
The molecular heritage of vascular injury: Apoptotic exosomes as drivers of renal inflammation and dysfunction
血管损伤的分子遗产:凋亡外泌体作为肾脏炎症和功能障碍的驱动因素
- 批准号:
461209 - 财政年份:2022
- 资助金额:
$ 2.83万 - 项目类别:
Operating Grants
The Lung Endothelium as an Instructive Niche for the Innate Immune System during Vascular Injury
肺内皮细胞作为血管损伤期间先天免疫系统的指导性生态位
- 批准号:
10706498 - 财政年份:2022
- 资助金额:
$ 2.83万 - 项目类别:
Drug abuse and HIV-associated pulmonary vascular injury
药物滥用和 HIV 相关肺血管损伤
- 批准号:
10330405 - 财政年份:2021
- 资助金额:
$ 2.83万 - 项目类别: